269 related articles for article (PubMed ID: 17575572)
1. An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.
Minick DJ; Copley RC; Szewczyk JR; Rutkowske RD; Miller LA
Chirality; 2007 Sep; 19(9):731-40. PubMed ID: 17575572
[TBL] [Abstract][Full Text] [Related]
2. A new class of histamine H3 receptor antagonists derived from ligand based design.
Roche O; Rodríguez Sarmiento RM
Bioorg Med Chem Lett; 2007 Jul; 17(13):3670-5. PubMed ID: 17498953
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
4. An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration.
Liu H; Kerdesky FA; Black LA; Fitzgerald M; Henry R; Esbenshade TA; Hancock AA; Bennani YL
J Org Chem; 2004 Jan; 69(1):192-4. PubMed ID: 14703397
[TBL] [Abstract][Full Text] [Related]
5. Determination of the absolute configuration and solution conformation of a novel disubstituted pyrrolidine acid A by vibrational circular dichroism.
Freedman TB; Cao X; Phillips LM; Cheng PT; Dalterio R; Shu YZ; Zhang H; Zhao N; Shukla RB; Tymiak A; Gozo SK; Nafie LA; Gougoutas JZ
Chirality; 2006 Sep; 18(9):746-53. PubMed ID: 16856170
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
[TBL] [Abstract][Full Text] [Related]
7. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
[TBL] [Abstract][Full Text] [Related]
8. Determination of the absolute configuration of chiral alpha-aryloxypropanoic acids using vibrational circular dichroism studies: 2-(2-chlorophenoxy) propanoic acid and 2-(3-chlorophenoxy) propanoic acid.
He J; Polavarapu PL
Spectrochim Acta A Mol Biomol Spectrosc; 2005 May; 61(7):1327-34. PubMed ID: 15820866
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the absolute configuration of JNJ-27553292, a CCR2 receptor antagonist, by vibrational circular dichroism analysis of two precursors.
Kuppens T; Herrebout W; Van Der Veken B; Corens D; De Groot A; Doyon J; Van Lommen G; Bultinck P
Chirality; 2006 Aug; 18(8):609-20. PubMed ID: 16715516
[TBL] [Abstract][Full Text] [Related]
10. Diastereoisomeric assignment in a pacifenol derivative using vibrational circular dichroism.
Muñoz MA; Chamy C; Carrasco A; Rovirosa J; Martín AS; Joseph-Nathan P
Chirality; 2009; 21 Suppl 1():E208-14. PubMed ID: 19899155
[TBL] [Abstract][Full Text] [Related]
11. Absolute configuration determination of chiral molecules in the solution state using vibrational circular dichroism.
Freedman TB; Cao X; Dukor RK; Nafie LA
Chirality; 2003 Nov; 15(9):743-58. PubMed ID: 14556210
[TBL] [Abstract][Full Text] [Related]
12. Model of a specific human histamine H3 receptor (hH3R) binding pocket suitable for virtual drug design.
Schlegel B; Stark H; Sippl W; Höltje HD
Inflamm Res; 2005 Apr; 54 Suppl 1():S50-1. PubMed ID: 15928832
[No Abstract] [Full Text] [Related]
13. Determination of the absolute configuration of the natural product Klaivanolide via density functional calculations of vibrational circular dichroism (VCD).
Devlin FJ; Stephens PJ; Figadère B
Chirality; 2009; 21 Suppl 1():E48-53. PubMed ID: 19743486
[TBL] [Abstract][Full Text] [Related]
14. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
[TBL] [Abstract][Full Text] [Related]
15. Assessment of configurational and conformational properties of naringenin by vibrational circular dichroism.
Abbate S; Burgi LF; Castiglioni E; Lebon F; Longhi G; Toscano E; Caccamese S
Chirality; 2009 Apr; 21(4):436-41. PubMed ID: 18655173
[TBL] [Abstract][Full Text] [Related]
16. Determination of the absolute configuration and solution conformation of gossypol by vibrational circular dichroism.
Freedman TB; Cao X; Oliveira RV; Cass QB; Nafie LA
Chirality; 2003 Feb; 15(2):196-200. PubMed ID: 12520512
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
[TBL] [Abstract][Full Text] [Related]
18. Structural determination of molecular stereochemistry using VCD spectroscopy and a conformational code: absolute configuration and solution conformation of a chiral liquid pesticide, (R)-(+)-malathion.
Izumi H; Ogata A; Nafie LA; Dukor RK
Chirality; 2009; 21 Suppl 1():E172-80. PubMed ID: 19899144
[TBL] [Abstract][Full Text] [Related]
19. Isotopic difference spectra as an aide in determining absolute configuration using vibrational optical activity: vibrational circular dichroism of 13C- and 2H-labelled nonamethoxy cyclotriveratrylene.
Freedman TB; Cao X; Luz Z; Zimmermann H; Poupko R; Nafie LA
Chirality; 2008 May; 20(5):673-80. PubMed ID: 18200587
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
